Walgreens shares are up about 13 percent over the past two months, with CNBC's Brian Sullivan and the FMHR team. Meanwhile strong fundamentals and dominant market positions make these biotech/pharma names stand out.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT